MedX Health Corp (MDXHF)
| Previous Close | 0.0350 |
| Open | 0.0350 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0350 - 0.0350 |
| 52 Week Range | 0.0350 - 0.0600 |
| Volume | |
| Avg. Volume | 161 |
| Market Cap | 11.653M |
| Beta (5Y Monthly) | 1.41 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
MedX Health and Health Partners announce the successful results of its pilot project in the United Kingdom and move towards a partnership agreement
MISSISSAUGA, Ontario, February 28, 2024--MedX Health Corp. ("MedX" or the "Company") (TSXV: MDX), a global leader in teledermatology, is pleased to announce they have successfully completed the pilot project with Health Partners. MedX and Health Partners are working together to begin the roll-out of this service to targeted clients engaged in a preventative approach to health care management.
- Business Wire
MedX Health Corp. announces Dr. Paul Cohen as Medical Spokesperson
MISSISSAUGA, Ontario, January 25, 2024--MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society. He was awar
- Business Wire
MedX Announces Intention to Seek Acceptance for Amendment to Series I Convertible Loan Notes
MISSISSAUGA, Ontario, December 12, 2023--MedX Health Corp. ("MedX" or the "Company") (TSX-V: MDX) is pleased to announce that it is making an Application to the TSX-V for Acceptance of the proposed amendment to the terms of the currently outstanding Convertible Loan Notes ("Series I Notes"). Following the conversion of five Series I Loan Notes during 2021, there are currently 75 Series I Loan Notes outstanding, with a face value of $3,750,000. The Series I Loan Notes, originally issued in the Fi
